MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Interpace Biosciences Depreciation & Amortization 2011-2026 | IDXG
Annual Depreciation & Amortization Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 425 K | 300 K | 1.03 M | 2.56 M | 5.37 M | 5.5 M | 4.52 M | 3.8 M | 3.69 M | 4.48 M | 5.03 M | 2.39 M | 1.42 M | 2.03 M | 3.05 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.5 M | 300 K | 3.04 M |
Quarterly Depreciation & Amortization Interpace Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 K | 101 K | 95 K | - | 85 K | 67 K | 52 K | - | 200 K | 300 K | 356 K | - | 300 K | 300 K | 781 K | - | 4.35 M | 2.94 M | 1.53 M | - | 4.1 M | 2.71 M | 1.32 M | - | 3.16 M | 1.92 M | 957 K | - | 2.58 M | 1.71 M | 855 K | - | 2.81 M | 1.94 M | 972 K | - | 3.49 M | 2.39 M | 1.26 M | - | 3.78 M | 2.5 M | 1.2 M | - | 1.33 M | 837 K | 457 K | - | 922 K | 577 K | 288 K | - | 1.49 M | 996 K | 501 K | - | 2.35 M | 1.56 M | 785 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.35 M | 52 K | 1.41 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
321 M | $ 115.55 | 1.0 % | $ 35.1 B |  USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.67 | -2.34 % | $ 2.22 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 21.23 | 5.83 % | $ 1.13 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 24.46 | 3.25 % | $ 679 M | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 16.31 | 1.75 % | $ 493 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Charles River Laboratories International
CRL
|
403 M | $ 169.8 | 1.23 % | $ 8.42 B | USA |
 |
Illumina
ILMN
|
354 M | $ 127.88 | 1.95 % | $ 20.3 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 88.91 | 1.18 % | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 84.33 | 1.82 % | $ 5.69 B | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 410.54 | 4.35 % | $ 11.8 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.54 | 2.03 % | $ 2.07 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.14 | -0.47 % | $ 4.92 M | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.23 | -0.12 % | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 102.17 | -3.92 % | $ 8.43 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 263.8 | -0.43 % | $ 21.9 B | USA |
 |
Celcuity
CELC
|
167 K | $ 121.03 | 6.58 % | $ 5.66 B | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.29 | 4.8 % | $ 1.06 B | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.78 | -0.21 % | $ 443 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 203.75 | 1.3 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 196.27 | -1.66 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
405 M | - | -0.91 % | $ 14.7 B | USA |
 |
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M | USA |
 |
Precipio
PRPO
|
1.24 M | $ 28.0 | 3.57 % | $ 44.9 M | USA |
 |
Personalis
PSNL
|
10.9 M | $ 6.1 | 3.39 % | $ 361 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 20.69 | 0.49 % | $ 223 M | China |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.56 | -0.64 % | $ 468 M | USA |